This study is in progress, not accepting new patients
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Fresno, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- ID
- NCT05500222
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 700 study participants
- Last Updated